Refractory and super-refractory status epilepticus and evidence for the use of ketamine: a scope review
Luis Espinosa, Mario Gomez, Adrian Zamora, Daniel Molano-Franco
J Neurocrit Care. 2023;16(1):1-9. Published online 2023 Jun 27 DOI: https://doi.org/10.18700/jnc.230003
Citations to this article as recorded by 
Ketamine plus midazolam compared to midazolam infusion for the management of refractory status epilepticus
Elizabeth W. Fletman, Sean Cleymaet, Amanda Salvatore, Kathryn Devlin, Allyson Pickard, Syed Omar Shah
Clinical Neurology and Neurosurgery.2024; 246: 108592. CrossRef
Renaissance of Ketamine
Kinga Kocur, Katarzyna Camlet, Anna Ziobro, Mateusz Ziomek, Wojciech Kaźmierski, Paulina Lis, Jakub Jurek, Anna Lis
Prospects in Pharmaceutical Sciences.2024; 22(3): 156. CrossRef
Status Epilepticus in a Tertiary Care Hospital in Morocco: A Retrospective Analysis
Ibrahim Bechri, Abdelkrarim Shimi, Ali Derkaoui, Mohammed Khatouf
Cureus.2023;[Epub] CrossRef
Management strategies for refractory status epilepticus
Jung-Won Shin
Journal of Neurocritical Care.2023; 16(2): 59. CrossRef